Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


New first-aid method could prevent brain damage in patients exposed to carbon monoxide


A new first-aid method of treating carbon monoxide poisoning could prevent brain damage in patients by delivering more oxygen to the brain than the standard treatment, according to a study by physicians at the Toronto General Hospital, University Health Network (UHN).

The study is published in the December issue of the U.S. based and peer-reviewed journal Annals of Emergency Medicine. The researchers, led by Dr. Josh Rucker, a Toronto General Hospital research fellow and resident in the Anesthesiology training program at the University of Toronto, studied 14 subjects who were exposed to low levels of carbon monoxide (resulting in blood levels about equal to those in heavy smokers) on two occasions in order to simulate conditions during carbon monoxide poisoning.

After each exposure, which lasted one hour, the participants were given one of two "test treatments": the standard treatment of 100% oxygen, or the new method consisting of a mixture of mostly oxygen and some carbon dioxide. Each participant received both test treatments in random order. Researchers then monitored the amount of oxygen in the blood and the blood flow to the brain during exposure to carbon monoxide and during the test treatments.


  • During the standard treatment with 100% oxygen, the flow of blood to the brain diminished, decreasing oxygen delivery to the brain. Results showed that the blood flow decreased by up to 33% and the oxygen delivered to the brain decreased by up to 20%.

  • Such a decrease in blood flow to the brain is sufficient to contribute to brain damage in a patient with severe carbon monoxide poisoning.

  • However, during treatment with the combination of oxygen and carbon dioxide, two effects were observed:

  • The delivery of oxygen to the brain was greater than during treatment with oxygen alone;

  • The rate of elimination of carbon monoxide increased by more than 20%.

"These results are intriguing," said Dr. Fisher, an anesthesiologist at Toronto General Hospital, University Health Network, Associate Professor in the Faculty of Medicine at the University of Toronto and a senior author of the study. "Most doctors believe that giving patients oxygen is like giving them chicken soup -- it can’t hurt. But, in fact, we find that treating carbon monoxide-exposed participants with pure oxygen actually limits the amount of oxygen that gets to their brains. That is worrisome."

"If severely poisoned patients respond like our test subjects, this new first-aid treatment may decrease the extent of brain damage in survivors," added Dr. Joseph Fisher.


  • This study raises the possibility that the standard first-aid treatment of carbon monoxide poisoning -- 100% oxygen - constricts blood vessels to the brain and decreases the total oxygen delivered to the brain.

  • Researchers think that the small amount of carbon dioxide in the oxygen counteracts the constriction of blood vessels to the brain

  • Although clinical studies need to be completed before recommending a change in the first-aid treatment of carbon monoxide poisoning, the results of this study suggest that simply maintaining carbon dioxide levels during treatment will result in more oxygen delivery to the brain, thereby decreasing the risk of permanent brain damage in severely poisoned patients.

  • Note: Adding carbon dioxide to oxygen during treatment for carbon monoxide poisoning was common in the late 1920s and 1930s.

  • It was thought then that the carbon dioxide stimulated breathing, helping to eliminate carbon monoxide more quickly, but was discontinued in the late 1940s when mechanical ventilators became available.

  • This study supports the re-introduction of this practice in order to maintain blood flow and oxygen delivery to the brain.


  • Carbon monoxide is the leading cause of fatal poisoning in the industrialized world, as well as being endemic in many parts of the developing world which use fossil fuels

  • In North America, it results in as many as 70,000 emergency room visits a year and in thousands of deaths

  • Up to 30 per cent of survivors of severe poisoning are left with disabling psychological and neurological symptoms, which sometimes last for years

  • Carbon monoxide is an odorless colorless gas formed during incomplete combustion of the fossil fuels - gas, oil, coal and wood used in boilers, engines, gas fires, water heaters, solid fuel appliances and open fires

  • When carbon monoxide is inhaled--even in tiny concentrations--it combines with the hemoglobin in the red blood cells to prevent the delivery of oxygen to the body

  • This results in few symptoms until the poisoning is advanced

  • Those suffering from carbon monoxide poisoning may initially complain of headache, nausea and fatigue but the symptoms can rapidly progress to coma and even death

  • It is therefore critical that carbon monoxide be eliminated from the body as soon and as quickly as possible

  • The only currently available emergency treatment for carbon monoxide poisoning is giving the patient 100 per cent oxygen

The study was supported, in part, by the Department of Anesthesia, University Health Network and the University of Toronto, and the Tobi and Ted Bekhor Foundation.

The Toronto General Hospital is a partner in University Health Network, along with Toronto Western and Princess Margaret Hospitals. The scope of research and complexity of cases at Toronto General Hospital has made it a national and international source for discovery, education and patient care. It has one of the largest hospital-based research programs in Canada, with major research projects in cardiology, transplantation, surgical innovation, infectious diseases, and genomic medicine. Toronto General Hospital is a teaching hospital affiliated with the University of Toronto.

To schedule an interview with Dr. Josh Rucker or Dr. Joseph Fisher, please contact:

Alex Radkewycz
Public Affairs
Toronto General Hospital, University Health Network
Phone: 416-340-3895
Pager: 416-980-0752

Marlene de Chellis | EurekAlert!

More articles from Health and Medicine:

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

Im Focus: Surveying the Arctic: Tracking down carbon particles

Researchers embark on aerial campaign over Northeast Greenland

On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...

Im Focus: Unique Insights into the Antarctic Ice Shelf System

Data collected on ocean-ice interactions in the little-researched regions of the far south

The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...

Im Focus: ILA 2018: Laser alternative to hexavalent chromium coating

At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.

When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...

Im Focus: Radar for navigation support from autonomous flying drones

At the ILA Berlin, hall 4, booth 202, Fraunhofer FHR will present two radar sensors for navigation support of drones. The sensors are valuable components in the implementation of autonomous flying drones: they function as obstacle detectors to prevent collisions. Radar sensors also operate reliably in restricted visibility, e.g. in foggy or dusty conditions. Due to their ability to measure distances with high precision, the radar sensors can also be used as altimeters when other sources of information such as barometers or GPS are not available or cannot operate optimally.

Drones play an increasingly important role in the area of logistics and services. Well-known logistic companies place great hope in these compact, aerial...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

International Virtual Reality Conference “IEEE VR 2018” comes to Reutlingen, Germany

08.03.2018 | Event News

Latest News

Wandering greenhouse gas

16.03.2018 | Earth Sciences

'Frequency combs' ID chemicals within the mid-infrared spectral region

16.03.2018 | Physics and Astronomy

Biologists unravel another mystery of what makes DNA go 'loopy'

16.03.2018 | Life Sciences

Science & Research
Overview of more VideoLinks >>>